By Amina Niasse and Sahil Pandey Oct 8 (Reuters) - The US government said on Thursday that about 71% of Medicare Advantage ...
October 8, 2026When you are about to prescribe a new medication in an outpatient setting, the electronic package insert ...
A US safety review identified reports of a rare, potentially life-threatening infection in people taking a widely used group ...
Consumption Tax on Additional BurdensThe Nikkei reported on October 8 that regarding the additional burden system for ...
The pharmaceutical industry’s top lobby group Pharmaceutical Research and Manufacturers of America (PhRMA) sued the Trump ...
Cost was cited at the top barrier to prescribing nonsteroidal mineralocorticoid antagonists (57%), sodium-glucose cotransporter 2 inhibitors (74%), and glucagon-like peptide 1 receptor agonists (84%).
Look at almost any photograph of an American crowd taken 60 years ago. It can be a baseball game, a high school graduation, a ...
Researchers report that the approved HIV protease inhibitor ritonavir binds the HCMV immediate-early protein IE1 and promotes its ubiquitin-proteasome-mediated degradation, inhibiting viral ...
A pooled analysis of four randomized trials found the dual neurokinin receptor antagonist elinzanetant showed no liver toxicity or cancer signals over 52 weeks, with mostly mild early side effects.
Maduro faces a June 2027 narco-terrorism trial, a $314M Miami torture judgment, and a Brooklyn civil suit by Venezuelan victims’ families.
On October 2, 2026, the Centers for Medicare & Medicaid Services (“CMS”) finalized the Global Benchmark for Efficient Drug Pricing (“GLOBE”) Model, ...
The new GLOBE model will link selected Medicare Part B drug rebates to prices in 19 countries, but exemptions have reduced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results